Business Description
Panacea Life Sciences Holdings Inc
NAICS : 325411
SIC : 2833
ISIN : US69810P1093
Description
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. Its products are CBD Softgels, CBD Tablets, CBD Topicals, CBD Skin Care, CBD Tinctures, CBD Edibles, CBD Patches, CBD Pets, and PPE.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -0.75 | |||||
| Debt-to-Equity | -1.83 | |||||
| Debt-to-EBITDA | -7.8 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -5.14 | |||||
| Beneish M-Score | -3.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -29.7 | |||||
| 3-Year EBITDA Growth Rate | -22.8 | |||||
| 3-Year EPS without NRI Growth Rate | -11.6 | |||||
| 3-Year FCF Growth Rate | 42.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.95 | |||||
| 9-Day RSI | 31.62 | |||||
| 14-Day RSI | 36.07 | |||||
| 3-1 Month Momentum % | -22.3 | |||||
| 6-1 Month Momentum % | 12.23 | |||||
| 12-1 Month Momentum % | -41.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.22 | |||||
| Quick Ratio | 0.03 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 1033.42 | |||||
| Days Sales Outstanding | 29.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 6.9 | |||||
| Shareholder Yield % | -189.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.34 | |||||
| Operating Margin % | -108.58 | |||||
| Net Margin % | -150.91 | |||||
| FCF Margin % | -27.76 | |||||
| ROA % | -35.69 | |||||
| ROIC % | -16.25 | |||||
| 3-Year ROIIC % | 3.52 | |||||
| ROC (Joel Greenblatt) % | -45.94 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.26 | |||||
| EV-to-EBIT | -5.24 | |||||
| EV-to-EBITDA | -8.16 | |||||
| EV-to-Revenue | 5.65 | |||||
| EV-to-FCF | -20.35 | |||||
| Price-to-GF-Value | 0.19 | |||||
| Earnings Yield (Greenblatt) % | -19.08 | |||||
| FCF Yield % | -90.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PLSH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Panacea Life Sciences Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.139 | ||
| EPS (TTM) ($) | -0.35 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 149.4 | ||
| 14-Day RSI | 36.07 | ||
| 14-Day ATR ($) | 0.006034 | ||
| 20-Day SMA ($) | 0.079997 | ||
| 12-1 Month Momentum % | -41.17 | ||
| 52-Week Range ($) | 0.0384 - 0.35 | ||
| Shares Outstanding (Mil) | 20.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Panacea Life Sciences Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Panacea Life Sciences Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Panacea Life Sciences Holdings Inc Frequently Asked Questions
What is Panacea Life Sciences Holdings Inc(PLSH)'s stock price today?
The current price of PLSH is $0.06. The 52 week high of PLSH is $0.35 and 52 week low is $0.04.
When is next earnings date of Panacea Life Sciences Holdings Inc(PLSH)?
The next earnings date of Panacea Life Sciences Holdings Inc(PLSH) is .
Does Panacea Life Sciences Holdings Inc(PLSH) pay dividends? If so, how much?
Panacea Life Sciences Holdings Inc(PLSH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers